Efficacy and Local Tolerability of Topically Applied Heparin (Heparin 2,400 IU /ml Cutaneous Spray) on the Suitability of Newly Constructed Primary Arteriovenous Fistulas in Patients Planned for Haemodialysis. A Multicentre, Randomized, Double-blind and Placebo-controlled Pilot Study
The primary objective of this study is to evaluate the effect of topically applied heparin in comparison to placebo on suitability of newly constructed primary arteriovenous fistulas in patients planned for haemodialysis at 7th week (± 1 week) after first study drug administration.
/ Not yet recruitingNot ApplicableIIT A single center, open, pilot study to evaluate the pharmacokinetic profile of a new galenic formulation of an Ambroxol-Hydrochloride (Ambroxol-HCl) spray: Ambroxol CYATHUS” 50 mg/mL Oral Spray, administered in a single dose of 30 mg Ambroxol-HCl to healthy male volunteers
100 Clinical Results associated with Cyathus Exquirere PharmaforschungsGmbH
0 Patents (Medical) associated with Cyathus Exquirere PharmaforschungsGmbH
100 Deals associated with Cyathus Exquirere PharmaforschungsGmbH
100 Translational Medicine associated with Cyathus Exquirere PharmaforschungsGmbH